MRSA research lags far behind AIDS in NIH support

Some researchers recently crunched the numbers of federal drug research support and concluded that despite all the alarms over drug-resistant superbugs each MRSA death translated into only $570 in grant funds. For AIDS, though, each death translates into $69,000 in grant money, reports Wired magazine. MRSA kills about 19,000 people in the U.S. every year. Story

Suggested Articles

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.

Lilly has created customized mobile research units to run the clinical trial as the long-term care facilities lack experience running studies.